Delayed response of insulin-stimulated fluorine-18 deoxyglucose uptake in glucose transporter-4-null mice hearts  by Simões, Marcus V et al.
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OBJECTIVES We sought to evaluate the time course of insulin-stimulated myocardial glucose uptake
(MGU) in mice that had undergone ablation of glucose transporter-4 (GLUT4).
BACKGROUND The relative importance of GLUT4, the most abundant insulin-responsive glucose trans-
porter, to modulate myocardial glucose metabolism is not well defined.
METHODS Myocardial glucose uptake was assessed at various time points after glucose (1 mg/g) and
insulin (8 mU/g) injection in GLUT4-null (G4N) (n  48) and wild-type (WT) (n  48)
mice with 18F-2-deoxy-2-fluoro-D-glucose (FDG) using in vivo positron emission tomog-
raphy (PET), in vitro gamma-counter biodistribution, and isolated, perfused hearts.
RESULTS Baseline assessment with PET imaging showed comparable MGU in G4N (0.66 0.12) and
WT (0.67  0.11, p  0.70) mice. Early after insulin injection, WT mice demonstrated a
3.5-fold increase in MGU (2.45 0.45, p 0.03), whereas G4N mice presented no increase
(1.11  0.24, p  0.28). At 60 min, MGU was comparable in G4N (3.19  0.60) and WT
(2.66  0.47, p  0.28) mice. In vitro gamma-counter biodistribution evaluation confirmed
in G4N mice a lack of MGU increase early after insulin, but a slow response over 120 min.
The isolated, perfused hearts of G4N mice during short-term (15 min) insulin stimulation
displayed no increase in MGU (0.08  0.01 ml/g/min), whereas WT mice presented a
threefold increase (0.22  0.01 ml/g/min, p  0.01). With long-term (60 min) insulin
stimulation, similar MGU was found in G4N (0.31  0.02 ml/g/min) and WT (0.33  0.04
ml/g per min, p  0.04) mice.
CONCLUSIONS The G4N mice displayed an increase of MGU in response to insulin similar to that of
controls, but with a markedly delayed time response. Our findings underscore the important
role of GLUT4 in the rapid adaptive response of myocardial glucose metabolism. (J Am
Coll Cardiol 2004;43:1690–7) © 2004 by the American College of Cardiology Foundationt
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to meet its high-energy demand, the working heart has the
bility to select the fuel among several exogenous substrates (1).
he majority of energy is derived from long-chain fatty acids,
ut myocardial cells can rapidly change their energy source by
timulation of glycolysis in response to ischemia, insulin,
ncreased workload, or catecholamine stimulation (2).
Recent observations have demonstrated that switching of
ubstrates and increasing glycolytic flux are important com-
ensatory mechanisms to cope with higher energy demand
nder pathologic conditions such as myocardial hypertrophy
3) and congestive heart failure (4). Furthermore, activation
f glycolysis seems to play a critical role as a protective
echanism during acute ischemia and infarction (5,6).
hese observations underscore the importance of studying
ardiac glucose metabolism, with direct implication for the
evelopment of new therapeutic strategies (7–9).
Several observations suggest that glucose transport
From the *Nuklearmedizinische Klinik und Poliklinik, Klinikum rechts der Isar der
echnischen Universita¨t Mu¨nchen, Munich, Germany; and †Department of Bio-
hemistry, Albert Einstein College of Medicine, Bronx, New York. This study was
upported by a grant from the Deutsche Forschungs Gemeinschaft (DFG, Schw
36/3) and by grants HL58119 and DK47425 (to Dr. Charron) from the National
nstitutes of Health, Bethesda, Maryland. Dr. Simo˜es is supported by FAPESP
esearch grant 01/04868-8.
Manuscript received July 20, 2003; revised manuscript received November 27,
003, accepted December 9, 2003.hrough the sarcolemma is a rate-limiting step of myocardial
lycolytic flux (10,11). Glucose enters cardiomyocytes
hrough specific glucose transporter (GLUT) proteins—
LUT1 and GLUT4 (12). The most abundant glucose
ransporter in the heart is GLUT4, which is localized
ainly in intra-cellular vesicles but is rapidly translocated to
he plasma membrane, providing increased glucose trans-
ort in response to insulin (13), catecholamine stimulation
14), increased workload, ischemia, and hypoxia (15). A
arge amount of GLUT1 in the myocardium is localized to
he sarcolemma and is considered to be responsible for basal
lucose transport, even though its translocation can also be
nduced by stimuli that provoke GLUT4 accumulation in
he sarcolemma (14,16,17).
Abnormalities in GLUTs have been demonstrated in
ssociation with changes in myocardial energy metabolism
n cardiac hypertrophy and failure (18,19) and in the
iabetic heart (20). In these conditions, a reduced sensitivity
o insulin stimulation is associated with diminished expres-
ion or activity of GLUT4. Even though the role of
LUT1 in regulating glucose metabolism of the heart has
een consistently demonstrated (9,21), the relative impor-
ance of GLUT4 remains unclear.A murine model with ablation of the GLUT4 gene has
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May 5, 2004:1690–7 Uptake of FDG in G4N Miceeen recently described (22). Besides retarded growth and
educed adipose tissue, these animals present myocardial
ypertrophy with normal systemic arterial blood pressure
nd depressed systolic function with aging (23). Despite
hese cardiac abnormalities, the only study to date investi-
ating myocardial metabolism in GLUT4-null (G4N) mice
nexpectedly reported myocardial glucose uptake (MGU)
omparable to that observed in wild-type (WT) control
nimals (24).
This study sought to investigate the changes in baseline
nd insulin-stimulated MGU in G4N and WT mice, using
n vivo positron emission tomographic (PET) imaging, in
itro gamma-counter tissue biodistribution studies, and
solated heart preparations measuring myocardial accumu-
ation of the positron-emitting glucose analogue 18F-2-
eoxy-2-fluoro-D-glucose (FDG).
ETHODS
nimals. Mice with disruption of the GLUT4 gene were
btained from Albert Einstein College of Medicine, Bronx,
ew York (22). Age-matched B6CBAF1/JICO WT mice
Charles River Laboratories, Sulzfeld, Germany) were con-
rols. The animals were fasted for 2 h before the studies.
he descriptive characteristics of the investigated mice are
isted in Table 1. The Bavarian Regional Ethic Committee
or Animal Research approved the protocols of animal care
nd experimentation.
aterials. Chemicals, unless otherwise specified, were
urchased from Sigma (Merck), Deisenhofen, Germany.
mmunoblotting of GLUTs. Membrane enrichment was
erformed with minor modifications (25). Briefly, samples
ere homogenized and submitted to centrifugation at 500 g
10 min) and 170,000 g (60 min). The resulting pellet was
issolved in homogenization buffer with 0.5% Triton
-100. The sample protein concentration was determined
y a commercial assay (BCA Protein Assay, Pierce, Rock-
Abbreviations and Acronyms
2-DG  2-deoxyglycose
FDG  18F-2-deoxy-2-fluoro-D-glucose
GLUT  glucose transporter
G4N  GLUT4-null mice
MGU  myocardial glucose uptake
PET  positron emission tomography
SUV  standard uptake value
WT  wild-type mice
able 1. Descriptive Characteristics of the Investigated Animals
n (M/F) Age (months)
LUT4-null mice 48 (21/27) 9.0  1.0
ild-type mice 48 (23/25) 9.8  1.0
Value* 0.592
Mann-Whitney U test. Data are presented as the mean value  SEM.
GLUT  glucose transporter.ord, Illinois). Per sample, 50 g protein was separated on
0% sodium dodecyl sulfate polyacrylamide gel, as previ-
usly described (25).
DG biodistribution experimental protocols. For gamma-
ounter biodistribution studies and PET imaging, animals
eceived intra-peritoneal injections of human insulin (8
U/g body weight) and glucose (1 mg/g body weight). A
ose of FDG (40 Ci) was injected in the tail vein under
ther inhalation anesthesia in relation to the insulin/glucose
pplication as follows: 1) simultaneous injection; 2) 30-min
elay; 3) 60-min delay; and 4) 120-min delay. The baseline
DG uptake was assessed without glucose/insulin injection.
ET imaging. Imaging by PET was performed at baseline,
fter simultaneous injection of the insulin/glucose solution
nd FDG, and after a 60-min delay. Animals were anes-
hetized with intra-muscular injection of midazolam (0.1
g/kg), fentanyl (1 g/kg), and medetomidin (10 g/kg).
mages were acquired in an EXACT HR scanner (CTI/
iemens, Erlangen, Germany) 40 min after intravenous
DG administration. Image acquisition protocols consisted
f 10-min static emission and 10-min transmission. The
mages were reconstructed using an iterative ordered subsets
xpectation maximization reconstruction algorithm with
ight subsets and four iterations. Three orthogonal plane
mages were generated for drawing regions of interest.
aximum FDG uptake values in the heart were obtained
or the standard uptake value (SUV) calculations, applying
orrections for body weight and injected activity.
amma-counter biodistribution studies. Animals were
uthanized 40 min after the FDG injection. The heart was
apidly harvested and rinsed in saline solution, and excess
iquid was removed. After weighing the organ, the radioac-
ivity was measured using a well gamma-counter (Cobra
uantum, Packard Instruments Company, Meriden). Car-
iac FDG uptake was then expressed as the SUV obtained
y calculating the ratio of myocardial FDG activity to
njected dose normalized to the body and heart weights.
solated heart perfusion preparation. Isolated heart per-
usion was used to investigate whether the results obtained
n the intact animal could also be obtained in an experi-
ental setting where systemic factors potentially influencing
lucose uptake are controlled (hormonal and metabolic
tates) by a standardized perfusate (14).
The preparation was performed as previously described
14). Briefly, the animals were euthanized under anesthesia
65 mg/kg intra-peritoneal sodium pentobarbital), and the
earts were harvested, placed in an ice-chilled buffer, and
Weight (g) Heart Weight (g)
Heart/Body Weight
Ratio (mg/g)
.8  1.1 0.205  0.01 7.032  0.49
.3  0.9 0.159  0.01 4.689  0.21
0.0004 0.0170 0.0001Body
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Uptake of FDG in G4N Mice May 5, 2004:1690–7ounted on a non-recirculating retrograde perfusion system
ia ascending aorta cannulation at a constant flow rate of 3
l/min (modified Langendorff preparation). The perfusate
onsisted of a modified Krebs-Henseleit-Bicarbonate buffer
pH 7.4), warmed at 37°C, oxygenated with 95% oxy-
en/5% carbon dioxide, and containing (in mmol/l): NaCl
17, KCl 4.7, MgSO4 1.1, KH2PO4 1.2, CaCl2 2.5,
aHCO3 20, and glucose 10.
A metal hook was inserted into the apex of the heart and
onnected to a tension transducer (GM3, Scaime Inc.,
edex, France), and the product of developed tension versus
eart rate was continuously monitored (26). The hearts were
llowed to stabilize for 10 min.
Then, FDG (10 Ci/ml of buffer) was added to the
erfusate at various time points, as described in the perfu-
ion protocols listed subsequently. The FDG accumulation
as measured by using two external coincidence detectors
nterfaced with a computer (14). The acquired data were
hen corrected for heart weight and buffer radioactivity
oncentration. The FDG uptake rate was obtained from the
igure 1. Western blot analysis of heart tissue for GLUT4 and GLUT1
roteins. As expected, there is an absence of the GLUT4 protein in
omozygous (/) GLUT4-null mice. The GLUT1 protein displays a
wofold increase in GLUT4-null mice (/) compared with wild-type
ice (/). GLUT  glucose transporter.
igure 2. Representative positron emission tomography images obtained i
t baseline, no myocardial [18F]-2-deoxy-2-fluoro-D-glucose (FDG) activ
f insulin and FDG, the wild-type mouse presented with increased radiot
he GLUT4-null mouse. After 60 min, both animals had conspicuous myocardlope of linear regression of the time-activity curve and
xpressed as ml/g/min.
Perfusate containing insulin (10 mU/ml) was used in an
ttempt to reproduce the time delays employed in the
iodistribution studies for short-term insulin stimulation
15-min perfusion with FDG-containing buffer allowed the
cquisition of baseline data; insulin was then added for an
dditional 15-min FDG uptake data acquisition) and long-
erm insulin stimulation (insulin-containing buffer was per-
used for 60 min with the FDG uptake data acquisition
erformed during the last 15 min).
tatistical analysis. Results are described as mean value 
EM. To test the significance of mean differences, non-
arametric distribution free tests were employed. The
ann-Whitney U test was used for non-paired samples,
nd the Wilcoxon matched-pairs test for paired samples. A
value 0.05 was considered significant.
ESULTS
he characteristics of the animals are described in Table 1.
ale and female animals were used, as gender did not
nfluence any of the parameters assessed. The difference in
ody weight reflects the retarded growth and reduced fat
issue in animals with GLUT4 gene disruption. A 29%
ncrease in heart weight and 50% increase in the heart/body
eight ratio were observed, compatible with myocardial
ypertrophy, as previously described in these genetically
odified animals (24).
Immunoblot analysis of myocardial tissue confirmed a
ack of GLUT4 protein in transgenic mice (Fig. 1). Protein
uantification obtained from three different membrane
-type and GLUT4-null mice under each of the experimental conditions.
s detected in the cardiac area of either animal. After simultaneous injection
uptake in the cardiac area (arrow), whereas no activity was identifiable inn wild
ity wa
racerial FDG uptake of comparable intensity. GLUT  glucose transporter.
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May 5, 2004:1690–7 Uptake of FDG in G4N Micereparations showed a 1.7  0.2-fold increase in the
xpression of GLUT1 when compared with WT mice (p 
.01).
ET imaging. Representative examples of PET images are
isplayed in Figure 2, and the mean data of the myocardial
DG uptake obtained through the analysis of PET images
re summarized in Figure 3A. A comparable radiotracer
etention in hearts from G4N and WT mice was obtained
n the non-stimulated baseline condition (p  0.84).
After simultaneous injection of insulin and FDG, WT
ice presented a significant 3.5-fold increase in FDG
ptake when compared with baseline (p  0.0079), while
aintaining similar levels of uptake after 60 min. On the
ther hand, the G4N mice presented no significant increase
n FDG uptake after simultaneous injection of insulin and
igure 3. Bar graphs summarizing the mean data of myocardial [18F]-2-
eoxy-2-fluoro-D-glucose (FDG) uptake in GLUT4-null and wild-type
ice (expressed as standard uptake values [SUVs], y-axis), using quanti-
ative analysis of (A) in vivo positron emission tomography imaging and
B) in vitro gamma-counter tissue biodistribution studies. The positron
mission tomography study was performed under the following conditions:
aseline, simultaneous injection of insulin and FDG, and 60-min delay.
he gamma-counter biodistribution study provides a more detailed time
ourse of insulin-stimulated FDG uptake as 30-min and 120-min delay
imes points were also investigated. *p  0.05 for comparisons with
aseline values. †p  0.05 for comparisons between GLUT4-null and
ild-type animals in each experimental condition. GLUT  glucose
ransporter.DG when compared with baseline (p 0.10). This uptakealue was significantly reduced compared with the result
btained in the corresponding WT group (p  0.032).
Under long-term insulin stimulation (60 min), G4N mice
ielded a significant fivefold increase in FDG retention (p
.008) and were comparable to the WT animals investi-
ated under the same experimental conditions (p  0.55).
amma-counter biodistribution studies. The results of
iodistribution studies confirmed the results obtained by
ET imaging that indicated a delayed response of FDG
ptake in the G4N animals compared with the WT
nimals. The mean data are summarized in Figure 3B. In
on-stimulated baseline conditions, comparable FDG up-
ake was detected in both animal groups (p  0.6857) (Fig.
B). However, there was a difference between G4N and
T mice regarding the time course of insulin stimulation in
DG uptake. Wild-type mice presented a significant 10-
old increase of FDG uptake after simultaneous injection,
ompared with the baseline condition (p  0.0286). The
aximum response of FDG uptake in WT animals oc-
urred at a 30-min delay between insulin and radiotracer
njection (about a 57-fold increase vs. baseline values, p 
.0286), a response level that remained constant at 60- and
20-min delays (p  0.0061 and 0.0159, respectively).
The G4N mice presented a delayed response in FDG
ptake, confirming imaging data. After simultaneous injection,
o significant increase in FDG uptake, compared with base-
ine, was detected (p  0.889). In addition, there was a
ignificant difference in FDG uptake between G4N and
orresponding WT animals observed after simultaneous injec-
ion (p  0.0286). Progressive augmentation of FDG uptake
as observed at 30, 60, and 120 min. Even though a significant
ncrease, compared with baseline, was demonstrated at 30 and
0 min (10- and 20-fold increases, p  0.0286 and 0.0061,
espectively), the responses of G4N mice were reduced when
ompared with those obtained in WT mice (p  0.0286 and
.0175, respectively). The maximum response in G4N mice
as found at 120 min, with FDG uptake values comparable in
oth animal types (Fig. 3B).
solated heart perfusion. The product of heart rate (beats/
in) times developed tension (g) was an index of cardiac
unction. At baseline, similar values were found in G4N
575.0  93.2 beats/min·g) and WT mice (757.1  80.3
eats/min·g, p  0.16). No significant difference was found
etween baseline and end perfusion values in either group
569.7  96.5 beats/min·g [p  0.81] and 780  91.5
eats/min·g [p 0.38] for G4N and WT hearts, respectively).
Representative traces of time-activity curves are displayed in
igure 4, and the mean data are summarized in Figure 5. The
DG uptake rate assessed in the isolated heart perfusion
reparation yielded comparable values in the G4N and WT
earts under baseline conditions (p  0.99). With the short-
erm insulin perfusion protocol, the WT animals presented a
ignificant threefold increase in the FDG uptake rate com-
ared with control values (p  0.0079), whereas G4N mice
earts presented no significant difference (p  0.22).
Under long-term insulin stimulation perfusion, a signif-
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Uptake of FDG in G4N Mice May 5, 2004:1690–7cantly higher FDG uptake rate was observed, compared
ith baseline, in both WT (p  0.04) and G4N mice (p 
.04). No significant difference was observed between WT
nd G4N mice hearts in the long-term perfusion protocols.
ISCUSSION
ur results, based on MGU obtained in vivo as well as in
solated heart preparation, demonstrated that G4N mice
earts elicit FDG uptake comparable to that observed in
T hearts in the baseline non-stimulated condition. As
xpected, G4N mice did not exhibit an early response in
DG uptake to insulin administration. However, GLUT4-
eficient hearts displayed FDG uptake similar to that of
T animals after 2-h exposure to insulin.
Few previous studies have investigated the consequences of
LUT4 gene ablation on myocardial metabolism (24,27,28).
o date, there has been only one study by Stenbit et al. (24),
hich investigated myocardial metabolism in the G4N mice
odel. Glucose uptake was assessed using the glucose analogue
-deoxyglycose (2-DG) and phosphorous-31 spectroscopy in
igure 4. Examples of [18F]-2-deoxy-2-fluoro-D-glucose (FDG) time-a
etectors. This approach allows the evaluation of insulin-stimulated myoc
nsulin effect: compared with the initial portion of the curve (baseline), an
ild-type mouse heart shortly after insulin is added to the perfusion buffe
fter the addition of insulin (arrow). (B) Long-term insulin stimulatio
dministration of insulin/glucose. In this condition, both GLUT4-null
orresponding baseline value. GLUT  glucose transporter.solated hearts perfused over 75 min. In contrast to our results, itenbit et al. (24) reported a higher 2-DG uptake rate in G4N
ice than in WT mice with insulin stimulation, and no late
ncrease in 2-DG uptake was found.
These discordances can be explained by methodologic dif-
erences of the isolated heart perfusion preparations. Firstly,
tenbit et al. (24) investigated hearts that were taken from
on-fasted animals. In this condition, the MGU rate is
ugmented at the beginning of perfusion and is unlikely to
how a further increase with the addition of insulin in the
erfusate (27). Secondly, the perfusate used by Stenbit et al.
24) included free fatty acids (palmitate, hydroxybutyrate) as
nergy substrates in addition to glucose. The oxidation of
ompetitive substrates can lead to inhibition of MGU (2). One
an speculate that inhibition of glucose uptake by competitive
ubstrates is less marked in the G4N mice, as they present
ecreased mRNA levels of enzymes of fatty acid oxidation, as
emonstrated by the Stenbit et al. (24) group, resulting in a
educed capacity of fatty acid oxidation.
On the other hand, the results of the present investigation
oncerning the normal baseline and deficient short-term,
curves obtained in isolated heart perfusion, using external coincidence
l FDG uptake without the influence of systemic factors. (A) Short-term
ease of the FDG uptake rate (slope of the curve segment) is seen in the
ow). Conversely, no change is observed in the GLUT4-null mouse heart
arts were perfused with insulin containing buffer 60 min after in vivo
ild-type hearts had an increased FDG uptake rate compared with thectivity
ardia
incr
r (arr
n: he
and wnsulin-stimulated FDG uptake are concordant with results
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May 5, 2004:1690–7 Uptake of FDG in G4N Micebtained by Tian and Abel (27), who investigated a trans-
enic mice model with selective ablation of the GLUT4
ene in heart tissue. Glucose uptake was also assessed in
solated hearts by measuring accumulation of the glucose
nalogue 2-DG with phosphorous-31 spectroscopy. In the
aseline condition, hearts from fasted GLUT4-deficient
nd control mice presented similar levels of glucose uptake.
uring a 16-min period of insulin administration, cardiac
LUT4-deficient mice did not present an increase in
lucose uptake, in contrast to control animals, which dem-
nstrated a marked increase.
One mechanism probably involved in the preserved
aseline glucose uptake in G4N mice is a compensatory
ncrease of myocardial GLUT1 content. Corroborating this
ypothesis, we demonstrated a 1.7-fold increase in GLUT1
rotein content in the myocardial tissue of G4N mice. This
nding is in agreement with the previous observations
eported by Katz et al. (22), who found a 1.5-fold increase
n GLUT1 myocardial content. Abel et al. (28) also re-
orted a threefold increase in myocardial GLUT1 content
n mice with selective ablation of GLUT4 in the heart.
owever, compensatory increases of additional GLUTs
ecently described cannot be discarded (29).
Despite the increased myocardial content of GLUT1, the
4N mice presented no elevation of basal FDG uptake.
his finding is in contrast to previous observations in which
ncreased GLUT1 expression was associated with aug-
ented baseline glucose uptake (21). Nonetheless, it is
lausible that the increase in GLUT1 expression in our
odel occurs in an extent needed to compensate for the
bsence of GLUT4 and to re-establish a normal, but not
ncreased, glucose transport level.
igure 5. Bar graph summarizing the mean data of the [18F]-2-deoxy-2-
uoro-D-glucose (FDG) uptake rate (expressed as ml/g/min, y-axis)
btained in isolated perfused hearts from GLUT4-null and wild-type mice
n each of the experimental conditions (x-axis). *p  0.05 for comparison
ith baseline. †p  0.05 for comparisons between GLUT4-null and
ild-type mice in each experimental condition. GLUT  glucose trans-
orter.It is conceivable that the increase in FDG uptake after grolonged insulin stimulation involves increased activity of
LUT1 by increased protein expression or translocation to
he sarcolemma and/or upregulation of its activity. This
ypothesis is supported by the results of one previous study
emonstrating that long-term insulin stimulation preferen-
ially upregulates GLUT1 expression, but not GLUT4, in
at hearts (30). Further evidence obtained in other insulin-
esponsive tissues submitted to long-term insulin stimula-
ion supports this hypothesis. Studies in rat adipocytes have
emonstrated maintenance of GLUT4 protein expression
nd increased GLUT1 expression when submitted to pro-
onged insulin stimulation (31). In addition, the trafficking
f GLUTs is also affected differentially by short- and
ong-term insulin stimulation. Cultured 3T3-L1 adipocytes
ubmitted to short-term (30 min) treatment with insulin
ncreased the surface labeling of GLUT1 and GLUT4 to
.5- and 12-fold, respectively. The expression of GLUT1 in
he cell membrane of cultured 3T3-L1 adipocytes submitted
o 24 h of insulin stimulation has been shown to be
arkedly increased (four-fold), whereas the level of
LUT4 at the cell surface was down-regulated (reduction
f 53%), suggesting that the increase in GLUT1 compen-
ates for the decrease in GLUT4 (32).
A further mechanism to explain the late insulin-
timulated increase in glucose uptake could be the stimula-
ion of glucose uptake secondary to the effect of a sharp
ecrease of plasma free fatty acid levels in G4N mice after
nsulin administration. However, this explanation is not
upported by our findings of increased insulin-stimulated
lucose uptake in isolated hearts, a more controlled condi-
ion in which the influences of a marked reduction of other
ubstrates’ availability for oxidation are absent. These results
uggest that an intrinsic myocardial mechanism, rather than
systemic metabolic effect, is responsible for the observed
hanges.
Myocardial insulin resistance can be defined as a de-
reased response of glucose uptake to the stimulatory effect
f insulin. This is a metabolic abnormality with a high
revalence and is associated with a number of pathologic
onditions, such as diabetes (20), myocardial hypertrophy
nd heart failure (18), and ischemic heart disease (33).
vidence derived from animal models (20,34,35) and clin-
cal studies (18) suggests that a reduced expression and/or
ctivity of GLUT4 is involved in the mechanism of insulin
esistance. Thus, our transgenic mouse model with absence
f GLUT4 can be considered as a model of extreme
yocardial insulin resistance. In this context, our results,
howing reduced FDG uptake shortly after insulin stimu-
ation, are concordant with previous observations in humans
n whom PET imaging was used and demonstrating re-
uced insulin-stimulated FDG uptake in patients exhibiting
nsulin resistance associated with cardiac hypertrophy and
schemic heart disease (33,36).
tudy limitations. Myocardial glucose uptake was assessed
y measuring FDG accumulation in this investigation. This
lucose analogue enters the myocardial cell through the same
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reviously reported that different stimuli or hormonal condi-
ions can produce differential hexokinase affinity for glucose as
ell as for the glucose analogue FDG, yielding different uptake
ates for each of these compounds (38). It was suggested that
he estimation of absolute glucose uptake rates using FDG is
ot reliable without applying specific correction constants for
very metabolic condition. Although this can represent a
imitation of the present investigation, FDG kinetics were used
s a functional index of glucose transport, and not for measur-
ng absolute myocardial glucose utilization. On the other hand,
his potential limitation does not affect the results obtained
rom the direct comparison of G4N and WT animals submit-
ed to the same experimental conditions.
This investigation used a PET scanner designed for human
linical studies. The inherent limited spatial resolution and the
onsequent partial volume effect were implicated in a reduced
ensitivity of the PET images when compared with gamma-
ounter biodistribution studies. This can explain the differences
etween the two methods in evaluating the magnitude of FDG
ptake increase after insulin (Figs. 3A and 3B).
onclusions. We demonstrated that the G4N mice lack
arly insulin-stimulated FDG uptake. Myocardial uptake of
DG in the G4N mice in response to insulin is delayed but
eaches levels comparable to those of control animals. Our
esults confirm a significant role of GLUT4 in the modu-
ation of glucose myocardial metabolism, as it allows for a
apid glucose transport adaptation. During prolonged or
ong-term stimulation, other mechanisms, probably involv-
ng regulation of GLUT1 activity/translocation, play an
mportant role in determining the glucose transport rate.
The findings of this study have potential implications in
athologic states in which reduced GLUT4 expression and
nsulin resistance were demonstrated, such as cardiac hyper-
rophy and diabetes (18,20). Although these patients
resent with preserved basal cardiac glucose metabolism and
unction, they demonstrate a poor tolerance to ischemia/
eperfusion injury, which can be related to the inability to
apidly adapt the rate of glycolysis (39,40).
cknowledgments
he authors gratefully acknowledge the technical assistance
f the PET staff for performing imaging acquisition and the
ET chemistry/cyclotron staff for the FDG production.
eprint requests and correspondence: Dr. Marcus V. Simo˜es,
uklearmedizinische Klinik und Poliklinik, Klinikum rechts der
sar der Technischen Universita¨t Mu¨nchen, Ismaninger Str. 22,
1675 Munich, Germany. E-mail: msimoes@fmrp.usp.br.
EFERENCES
1. Depre C, Vanoverschelde JLJ, Taegtmeyer H. Glucose for the heart.
Circulation 1999;99:578–88.
2. Depre C, Rider MH, Hue L. Mechanisms of control of heart
glycolysis. Eur J Biochem 1998;258:277–90.3. Scho¨nekess BO, Allard MF, Lopashuk GD. Propionyl L-carnitine
improvement of hypertrophied heart function is accompanied by an
increase in carbohydrate oxidation. Circ Res 1995;77:726–34.
4. Friehs I, Moran AM, Stamm C, et al. Impaired glucose transporter
activity in pressure-overload hypertrophy is an early indicator of
progression to failure. Circulation 1999;100 Suppl II:II187–93.
5. Kudej RK, White LT, Kudej AB, et al. Brief increase in carbohydrate
oxidation after reperfusion reverses myocardial stunning in conscious
pigs. Circulation 2002;106:2836–41.
6. Vanoverschelde JJ, Janier MF, Bakke JE, Marshall DR, Bergmann SR.
Rate of glycolysis during ischemia determines extent of ischemic injury
and function recovery after reperfusion. Am J Physiol 1994;267:
H1785–94.
7. Opie LH, Sack MN. Metabolic plasticity and the promotion of cardiac
protection in ischemia and ischemic preconditioning. J Mol Cell
Cardiol 2002;34:1077–89.
8. Apstein CS. Glucose-insulin-potassium for acute myocardial infarc-
tion: remarkable results from a new prospective, randomized trial.
Circulation 1998;98:2223–6.
9. Taegtmaeyer H. Switching metabolic genes to build a better heart.
Circulation 2002;106:2043–5.
0. Manchester J, Kong X, Nerbonne J, et al. Glucose transport and
phosphorylation in single cardiac myocytes: rate-limiting steps in
glucose metabolism. Am J Physiol 1994;266:E326–33.
1. King LM, Opie LH. Glucose delivery is a major determinant of
glucose utilization in the ischemic myocardium with a residual coro-
nary flow. Cardiovasc Res 1998;39:381–92.
2. Mueckler M. Family of glucose transporter genes: implication for
glucose homeostasis and diabetes. Diabetes 1990;39:6–11.
3. Slot JW, Geuze HJ, Gigengack S, James DE, Lienhard GE. Trans-
location of the glucose transporter GLUT4 in cardiac myocytes of the
rat. Proc Natl Acad Sci USA 1991;88:7815–9.
4. Egert S, Nguyen N, Schwaiger M. Contribution of -adrenergic and
-adrenergic stimulation to ischemia-induced glucose transporter
GLUT4 and GLUT1 translocation in the isolated perfused rat heart.
Circ Res 1999;84:1407–15.
5. Sun D, Nguyen N, Degrado TR, Schwaiger M, Brosius FC 3rd.
Ischemia induces translocation of the insulin-responsive glucose trans-
porter GLUT4 to the plasma membrane of cardiac myocytes. Circu-
lation 1994;89:793–8.
6. Fischer Y, Thomas J, Sevilla L, et al. Insulin-induced recruitment of
glucose transporter 4 (GLUT4) and GLUT1 in isolated rat cardiac
myocytes. J Biol Chem 1997;272:7085–92.
7. Young LH, Renfu Y, Russell R, et al. Low-flow ischemia leads to
translocation of canine heart GLUT4 and GLUT1 glucose transport-
ers to the sarcolemma in vivo. Circulation 1997;95:415–22.
8. Paternostro G, Pagano D, Gnecchi-Ruscone T, Bonser RS, Camici
PG. Insulin resistance in patients with cardiac hypertrophy. Cardio-
vasc Res 1999;42:246–53.
9. Razeghi P, Young ME, Cockrill TC, Frazier OH, Taegtmeyer H.
Downregulation of myocardial myocyte enhancer factor 2C and
myocyte enhancer factor 2C-regulated gene expression in diabetic
patients with nonischemic heart failure. Circulation 2002;106:407–11.
0. Kainulainen H, Breiner M, Schurmann A, Marttinem A, Virjo A,
Joost HG. In vivo glucose uptake and glucose transporter proteins
GLUT1 and GLUT4 in heart and various types of skeletal muscle
from streptozotocin-diabetic rats. Biochim Biphys Acta 1994;1225:
275–82.
1. Liao R, Jain M, Cui L, et al. Cardiac-specific overexpression of
GLUT1 prevents the development of heart failure attributable to
pressure overload in mice. Circulation 2002;106:2125–31.
2. Katz EB, Stenbit AE, Hatton K, DePinho R, Charron MJ. Cardiac
and adipose tissue abnormalities but not diabetes in mice deficient in
GLUT4. Nature 1995;377:151–5.
3. Weiss RG, Chathan JC, Georgakopolous G, et al. Effect of GLUT4
ablation on in vivo cardiac energetics and function in adult senescent
mice. FASEB J 2002;16:613–5.
4. Stenbit AE, Katz EB, Chatham JC, et al. Preservation of glucose
metabolism in hypertrophic GLUT4-null hearts. Am J Physiol 2000;
279:H313–8.
5. Ryder JW, Kawano Y, Chibalin AV, et al. In vitro analysis of the
glucose transport system in GLUT4-null skeletal muscle. Biochem J
1999;342:321–8.
22
2
2
3
3
3
3
3
3
3
3
3
3
4
1697JACC Vol. 43, No. 9, 2004 Simo˜es et al.
May 5, 2004:1690–7 Uptake of FDG in G4N Mice6. Tada H, Thompson CI, Recchia FA, et al. Myocardial glucose uptake
is regulated by nitric oxide via endothelial nitric oxide synthase in
Langendorff mouse heart. Circ Res 2000;86:270–4.
7. Tian R, Abel D. Responses of GLUT4-deficient hearts to ischemia
underscore the importance of glycolysis. Circulation 2001;103:2961–6.
8. Abel ED, Kaulbach HC, Tian R, et al. Cardiac hypertrophy with
preserved contractile function after selective deletion of GLUT4 from
the heart. J Clin Invest 1999;104:1703–14.
9. Joost HG, Bell GI, Best JD, et al. Nomenclature of the GLUT/
SLC2A family of sugar/polyol transport facilitators. Am J Physiol
Endocrinol Metab 2002;282:E974–6.
0. Laybutt DR, Thompson AL, Cooney GJ, Kraegen EW. Selective
chronic regulation of GLUT1 and GLUT4 content by insulin,
glucose, and lipid in rat cardiac muscle in vivo. Am J Physiol
1997;273:H1309–16.
1. Pryor PR, Liu SC, Clark AE, Yang J, Holman GD, Tosh D. Chronic
insulin effects on insulin signaling and GLUT4 endocytosis are
reversed by metformin. Biochem J 2000;348:83–91.
2. Kozka IJ, Clark AE, Holman GD. Chronic treatment with insulin
selectively down-regulates cell-surface GLUT4 glucose transporters in
3T3-L1 adipocytes. J Biol Chem 1991;266:11726–31.
3. Paternostro G, Camici PG, Lammerstma AA, et al. Cardiac and
skeletal muscle insulin resistance in patients with coronary artery
disease: a study with positron emission tomography. J Clin Invest
1996;98:2094–9.4. Paternostro G, Clarke K, Heath J, Seymour AM, Radda GK.
Decreased GLUT-4 mRNA content and insulin-sensitive deoxyglu-
cose uptake show insulin resistance in the hypertensive rat heart.
Cardiovasc Res 1995;30:205–11.
5. Friehs I, Moran AM, Stamm C, et al. Impaired glucose transporter
activity in pressure-overload hypertrophy is an early indicator of
progression to failure. Circulation 1999;100 Suppl II:II187–93.
6. Kofoed KF, Carstensen S, Hove JD, et al. Low whole-body insulin
sensitivity in patients with ischemic heart disease is associated with
impaired myocardial glucose uptake predictive of poor outcome after
revascularization. Eur J Nucl Med 2002;29:991–8.
7. Schelbert HR, Phelps ME, Hoffman E, Huang SC, Kuhl DE.
Regional myocardial blood flow, metabolism, and function assessed
noninvasively with positron emission tomography. Am J Cardiol
1980;46:1269–77.
8. Hariharan R, Bray M, Ganim R, Doenst T, Goodwin GW, Taegt-
meyer H. Fundamental limitations of [18F]2-deoxy-2-fluoro-D-
glucose for assessing glucose uptake. Circulation 1995;91:2299–301.
9. Mochizuki T, Eberli FR, Ngoy S, et al. Effects of brief repetitive
ischemia on contractility, relaxation, and coronary flow: exaggerated
postischemic diastolic dysfunction in pressure-overload hypertrophy.
Circ Res 1993;73:550–8.
0. Abbud ZA, Shindler DM, Wilson AC, et al., the Myocardial
Infarction Data Acquisition System Study Group. Effect of diabetes
mellitus on short- and long-term mortality rates of patients with acute
myocardial infarction: a statewide study. Am Heart J 1995;130:51–8.
